RxDoctor Payments Data

Janice Gorski

Nurse Practitioner · Milwaukee, WINPI 1952927972

Payments from drug & device makers

$4,505in general payments, 2019–2025

Across 53 payments — averaging $85.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hollister Incorporated$1K
  • Convatec Inc.$1K
  • Coloplast$517
  • Smith+Nephew$449
  • Medline Industries LP$184
  • KCI USA, Inc.$158
  • plus $710 from 8 others

What the payments were for

  • Food & beverage$4,505100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Hollister Incorporated11$1,435
Convatec Inc.16$1,052
Coloplast4$517
Smith+Nephew8$449
Medline Industries LP2$184
KCI USA, Inc.2$158
Urgo Medical North America, LLC1$150
Organogenesis Inc.1$145
Kerecis Limited2$131
Bsn Medical Inc1$107
Hartmann USA, Inc.1$80
Solventum Corporation2$70
180 Medical, Inc.1$20
Medela LLC1$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,505 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$20,362
Medicare patients
69
Services billed
315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nystatin12$157
NystopNystatin18$110

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →